Insulin resistance is accompanied by hyperinsulinemia, which can drive hepatic lipid accumulation by stimulating de novo lipogenesis via the transcriptional master regulator SREBP1c (2). The gene discussed is SREBF1; the disease is Hyperinsulinemia.